Target intelligence / Profile preview

SMCR8-C9orf72 complex subunit (SMCR8)

Target
SMCR8
Molecular classification
GTPase-activating protein (GAP), Guanine nucleotide exchange factor (GEF), DENN domain-containing protein, Other
01

Overview

SMCR8-C9orf72 complex subunit (SMCR8) is a protein that forms a stable heterotrimeric complex with C9ORF72 and WDR41, primarily regulating autophagy, membrane trafficking, and lysosomal homeostasis[1][3][6]. SMCR8 contains Longin and DENN domains, consistent with its function as a GTPase-activating protein (GAP) and guanine nucleotide exchange factor (GEF) for small GTPases, notably RAB and ARF family proteins[1][3][5][8]. It has a central role in modulating the activation state of RAB8A, RAB11A, and ARF1 through its DENN domain and a conserved arginine finger, regulating processes like autophagosome maturation and mTORC1 signaling[1][8]. Mutations or loss of SMCR8 and its associated complex have been linked to neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), as well as lysosomal and immune system dysfunction[2][4][5][6]. SMCR8 is also associated with protein ubiquitination pathways, interacts with chromatin in the nucleus, and acts as a negative regulator of lysosomal exocytosis[5][7][9]. No direct drug interactions are known to date.

Other names
Guanine nucleotide exchange protein SMCR8DENND8ASmith-Magenis syndrome chromosomal region candidate gene 8 proteinFLJ34716SMCR8-C9orf72 complex subunitSmith-Magenis syndrome chromosome region, candidate 8
02

Mechanism of action

Regulates small GTPase activity (GAP activity for Rab8a, Rab11a, ARF1) GEF activity for RAB proteins (RAB8A, RAB39B) Regulation of autophagosome maturation Regulation of mTORC1 pathway via modulation of lysosomal signaling

03

Biological functions

Regulation of autophagyMembrane traffickingRegulation of mTORC1 signalingLysosomal functionNegative regulation of lysosomal exocytosisProtein ubiquitination and degradation
04

Disease associations

Neurodegenerative disease (Amyotrophic lateral sclerosis, Frontotemporal dementia)Smith-Magenis syndromeBirt-Hogg-Dube syndromeAutoimmunity
05

Safety considerations

Loss of function or disruption implicated in neurodegeneration (ALS, FTD)[2][3][6]Dysfunction may contribute to autophagy defects and immune dysregulation[4][9]

Beyond the preview

Go deeper on SMCR8-C9orf72 complex subunit (SMCR8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMCR8-C9orf72 complex subunit (SMCR8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call